USA >> Company >> Board of Directors

Board of Directors

Peter J. Fitzgerald

Dr. Peter Fitzgerald is an Interventional Cardiologist and a Professor of Medicine at Stanford University, where he is the Director of the Center for Cardiovascular Technology and the Director of the Cardiovascular Core Analysis Laboratory. Dr. Fitzgerald has led and/or participated in over 100 clinical trials and has published over 350 articles and chapters in medical journals and text books.

In addition to his clinical expertise, Dr. Fitzgerald is able to gain granularity on a technology level, having a PhD in Biomedical Engineering. Furthermore, Dr. Fitzgerald brings extensive venture and start up experience to the fund, having been part of the founding team of more than a dozen medical device start ups, and having been one of the principle founders of Latterell Venture Partners, a large healthcare focused venture capital fund located in Silicon Valley. Dr.Fitzgerald serves on several boards, and is an advisor to many medical device start-ups and multinational healthcare companies.

Mike Berman

Mr.Berman is a co-founder of Aetherworks, Apnex, BeneChill, and BridgePoint Medical. In addition he is an investor and board member of Data Sciences Int’l, Lutonix, PharmaCentra and UltraShape. In 2001 he co-founded Velocimed which was sold to St. Jude Medical in 2005. From 1995-2000 Mr. Berman was the President of the Cardiology business of Boston Scientific.Mr. Berman received his BS and MBA degrees from Cornell University in 1979 and 1986, respectively.

Ilan Neugarten

Mr. Neugarten joined the Viola Partners Group in 2000 as a partner of DOR Ventures, a VC fund focusing on imaging technologies. During his period at DOR Ventures he led various investments including medical imaging ventures. Since 2006, he has led the healthcare investments of VPartners, and currently serves on the boards of Angioslide,  eurosonix, and PainReform. Prior to joining the Viola Partners Group, he worked for Scitex (NASDAQ:SCIX) in various management positions in Europe, Japan, and Israel. He received his BSc in Electronics from the Technion and an MBA from Boston University, USA.

Ariel Moses

Ariel Moses is a managing partner & CFO with the Agate Medical Investments VC Funds, leading investments and portfolio managements. Mr. Moses is a board member with the following medical device companies: 'MST'(surgery robotics), 'Tulip'(obesity device), and 'AngioSlide' (angioplasty). Ariel served as CEO & board member with 'Iscare Healthcare B.V.' (medical centers in Europe) - led turn around to profitability and exit by M&A. Mr. Moses is Co-Founder at 'Ilumi labs' (Aesthetic dermatology) and 'Incede' (regulation & validation) where he is also a board member. Prior to Agate: Founder & CEO of 'Clal TIS' (FinTech) of Clal Finance investment company, Analyst and VP with leading financials corporations.

a site by razgroup © 2011 Angioslide. All Rights Reserved. Careers Legal Notice Site Map